| SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4 A Bertrand-Chapel, C Caligaris, T Fenouil, C Savary, S Aires, S Martel, ... Communications Biology 5 (1), 1068, 2022 | 27 | 2022 |
| H3.3K27M mutation controls cell growth and resistance to therapies in pediatric glioma cell lines A Rakotomalala, Q Bailleul, C Savary, M Arcicasa, M Hamadou, ... cancers 13 (21), 5551, 2021 | 11 | 2021 |
| Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells by modulating metabolism and death pathways J Vial, P Huchedé, S Fagault, F Basset, M Rossi, J Geoffray, H Soldati, ... Cell death discovery 6 (1), 64, 2020 | 10 | 2020 |
| Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers C Savary, L Luciana, P Huchedé, A Tourbez, C Coquet, M Broustal, ... Cell Reports Medicine 4 (12), 2023 | 6 | 2023 |
| The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel P Huchedé, P Leblond, M Castets Biomedicines 10 (6), 1311, 2022 | 6 | 2022 |
| Alterations of the TGFb-sequestration complex member ADAMTSL1 levels are associated with muscular defects and rhabdomyosarcoma aggressiveness G Juban, A Bertrand-Chapel, S Meyer, A Kneppers, P Huchedé, ... bioRxiv, 2023.03. 07.531559, 2023 | 2 | 2023 |
| BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas P Huchedé, S Meyer, C Berthelot, M Hamadou, A Bertrand-Chapel, ... bioRxiv, 2023.08. 09.552628, 2023 | 1 | 2023 |
| Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old? C Berthelot, P Huchedé, A Bertrand-Chapel, PA Beuriat, P Leblond, ... International Journal of Molecular Sciences 25 (6), 3361, 2024 | | 2024 |
| Impact of the H3.3K27M Mutation on the Response to Treatments of DIPG Cells P Lewandowski, A Rakotomalala, S Bouaouda, M Le Grand, Q Bailleul, ... 5e colloque du React4Kids «Childhood cancers: understand to treat», 2023 | | 2023 |
| Alterations of the TGFb-sequestration complex member ADAMTSL1 levels are associated with muscular defects and rhabdomyosarcoma aggressiveness A Bertrand-Chapel, S Meyer, G Juban, A Kneppers, P Huchedé, ... | | 2023 |
| Développement et caractérisation de modèles cellulaires originaux pour l’étude du rôle de l’oncohistone H3.3K27M dans le phénotype agressif et résistant des cellules de DIPG A Rakotomalala, P Lewandowski, S Bouaouda, Q Bailleul, M Le Grand, ... Journées du Cancéropôle Nord-Ouest, 2023 | | 2023 |
| Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors P Piris, D Buric, T Yamasaki, P Huchedé, M Rossi, M Matteudi, ... Chemical Science 14 (29), 7988-7998, 2023 | | 2023 |
Adrien Bertrand-ChapelPostdoctoral researcher, Cancer Research Center of Lyon, Université Claude Bernard Lyon 1在 lyon.unicancer.fr 的电子邮件经过验证
